Mild to Moderate Psoriasis Research Study (41 Weeks)

Adults 18 years of age or older with a diagnosis of chronic plaque psoriasis for at least 6 months, may qualify to participate. Eligible participants must have plaque psoriasis covering 2-15% of their body, with mild to moderate disease at the time of study entry.

Eligible participants will receive investigational oral medication (active drug) or placebo. During the extension phase all participants will receive active drug. Study medication and study-related care will be provided at no cost. Reimbursement for study-related expenses may be provided.

Study participation will last about 41 weeks and include about 11 visits to the study centre.

Call the study centre near you, or register now.

Learn more about
Psoriasis
Register Now!

Register for
Active Studies!

Register

All information about you will be kept confidential.

If there are no active studies for your condition, we will keep your information and contact you when a new study starts in your area.

By registering you are consenting to the terms and conditions of our privacy policy.

Find the clinic near you:

Why Take Part In a Clinical Study?

Regulatory agencies like Health Canada, Australia's Therapeutic Goods Administration and the FDA require that Clinical Research Trials be conducted in order to develop new treatments, preventions and devices for diseases or conditions. Clinical Research Trials are also referred to as Clinical Studies or Clinical Trials. read more